Donald Trump has issued an executive order to terminate all federal funding for risky virus research in countries deemed ...

BioCryst Pharmaceuticals, Inc.’s BCRX share price has surged by 14.00%, which has investors questioning if this is right time to sell.

President Donald Trump signed an executive order Monday updating guidance for researchers and government agencies with the ...

Donald Trump's latest executive order has sent ripples through the scientific community, halting US funding for controversial ...

The Trump administration’s $500 million investment in an old flu vaccine approach has raised concerns among experts, who ...

Urban rats spread a deadly bacteria as they migrate within cities that can be the source of a potentially life-threatening disease in humans, according to a six-year study by Tufts University ...

President Trump signed an executive order Monday to ban all federal funding of risky gain-of-function research in China, Iran ...

MasterControl says its Quality Excellence Gov (Qx Gov) solution is the first industry-leading QMS to achieve this rigorous ...

The U.S. Department of Health and Human Services and the National Institutes of Health announced a new initiative called ...

Steven Hatfill promoted hydroxychloroquine during the pandemic. Decades earlier he was wrongly connected with the anthrax ...

After spending years tracing the origin and migration pattern of an unusual type of immune cell in mice, researchers have shown in a new study how activity of 'good' microbes in the gut is linked to ...

NIH program to make vaccines against pathogens that can trigger pandemics uses approach pioneered in last century ...